# Katerina Stroponiati

> Katerina Stroponiati is a pre-seed investor at Monday Capital backing Medical and Life Science. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Monday Capital](https://shizune.co/investors/profile/monday-capital)
- Location: San Francisco, United States
- Total investments: 1
- Last investment: Jun 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/katerina-stroponiati/30/2a2/bb8
- X (Twitter): http://twitter.com/katerinastro
- Website: https://brilliant-minds.com/
- Facebook: http://www.facebook.com/katerina.stroponiati

Katerina Stroponiati is a pre-seed investor at Monday Capital in San Francisco focused on Medical and Life Science. Katerina Stroponiati is the founder of Brilliant Minds, pioneering a visionary approach in venture capital by focusing on founders over 50, challenging age-related stigmas in entrepreneurship. Brilliant Minds is a longevity intervention with a twist, demonstrating that older individuals can be innovative and forward-thinking. Previously,Katerina's two tech startups had successful exits. With an engineering background and experience as an ex-startup founder and founding partner of Monday Capital, Katerina brings a unique perspective to the field of entrepreneurship.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biophysical Therapeutics | Biophysical Therapeutics uses computational biology to design new drugs. It has a pipeline of experimentally-validated new drugs. Its primary targets are cancer, diseases of aging (e.g., Alzheimer's disease), and aging itself. Also pursuing cosmetics. Has a record of discovering new fundamental biology. Owns [by granted patents] inventedpreclinical, and repurposed clinical, stage drugs. Company has and is prosecuting longevity drug candidates (drugs to slow, halt or reverse aging). A longevity company. Professor George Church (of Harvard Medical School) is an Advisor. Scientist founder, Dr. Michael Forrest, is a Cambridge University biochemistry graduate with a Ph.D. in computer science. | $190K | Pre-Seed | Jun 05, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Reinforced Ventures](https://shizune.co/investors/profile/reinforced-ventures) — VC Fund, 1 deal together
- [Wefunder](https://shizune.co/investors/profile/wefunder) — VC Fund, 1 deal together

## About Monday Capital

VC Fund · San Francisco, United States

Venture Capital with a focus on Blockchain, AI and VR

1 contacts available at Monday Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Katerina Stroponiati | Founding Partner | https://shizune.co/investors/profile/katerina-stroponiati |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Katerina Stroponiati invest in?

Katerina Stroponiati invests primarily in Medical, Life Science and Therapeutics startups, most often at Pre-Seed stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Katerina Stroponiati last invest?

The most recent investment recorded for Katerina Stroponiati closed in Jun 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co